Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16474-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16474-1-AP, RRID:AB_2223855
- Product name
- ADH4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ADH4 antibody (Cat. #16474-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling.
Bioinformatics identification of key microRNA-correlated genes associated with hepatocellular carcinoma heterogeneity and prognosis.
Crosstalk of non-apoptotic RCD panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization.
ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications.
Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes.
Tian Y, Bao X, Lei S, Huang Y, Wang X, Tu Y, He Q, Zhang F, Xu H, Ashrafizadeh M, Sethi G, Wang F, Zeng Z
Cell communication and signaling : CCS 2025 Jul 10;23(1):329
Cell communication and signaling : CCS 2025 Jul 10;23(1):329
Bioinformatics identification of key microRNA-correlated genes associated with hepatocellular carcinoma heterogeneity and prognosis.
Su G, Li Y, Wang J, Liu S, Pan G, Zhan D
BMC gastroenterology 2025 Jul 1;25(1):452
BMC gastroenterology 2025 Jul 1;25(1):452
Crosstalk of non-apoptotic RCD panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization.
Li S, Xu Y, Hu X, Chen H, Xi X, Long F, Rong Y, Wang J, Yuan C, Liang C, Wang F
iScience 2024 Jun 21;27(6):109901
iScience 2024 Jun 21;27(6):109901
ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications.
Li L, Huang YT, Wang LT, Wang XL, Chen ZY, Jiang SL, Zeng QL, Huang HP, Li XL
BMC cancer 2024 Aug 1;24(1):927
BMC cancer 2024 Aug 1;24(1):927
Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J
Frontiers in immunology 2022;13:994259
Frontiers in immunology 2022;13:994259
Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes.
Ye T, Lin L, Cao L, Huang W, Wei S, Shan Y, Zhang Z
Frontiers in oncology 2022;12:863266
Frontiers in oncology 2022;12:863266
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse liver tissue were subjected to SDS PAGE followed by western blot with 16474-1-AP(ADH4 antibody) at dilution of 1:200
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 16474-1-AP(ADH4 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ADH4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ADH4. This antibody recognizes human,mouse,rat antigen. The ADH4 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
